8-K: KindlyMD Approves $10M Share Buyback, Elects Directors
Annual Meeting Results and Share Repurchase Program Announcement
KindlyMD's stockholders approved key proposals at its annual meeting, including director elections and a corporate conversion, and the company authorized a $10 million share repurchase program.
Summary
- Kindly MD, Inc. held its annual meeting of stockholders on December 17, 2025, with 262,599,301 shares, or approximately 60.84% of outstanding shares, represented, establishing a quorum.
- Stockholders elected Perianne Boring and Greg Xethalis as Class I directors, each to serve for a three-year term expiring at the company's 2028 annual meeting.
- The conversion of Kindly MD from a Utah corporation to a Delaware corporation was approved by stockholders with 178,012,673 votes for.
- The appointment of Sadler, Gibb & Associates, LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified by stockholders with 261,930,018 votes for.
- Stockholders approved the adjournment of the annual meeting to a later date or dates, if necessary, to permit further solicitation and voting of proxies.
- The Board of Directors approved a 2025 Repurchase Program on December 18, 2025, authorizing the repurchase of up to $10 million of the company's outstanding common stock.
- The company entered into a Rule 10b-18 Repurchase Plan with TD Securities Inc. to act as a non-exclusive agent for repurchases, with a commission rate of $0.0075 for each share repurchased.
Sentiment
Score: 8
Explanation: The filing indicates strong corporate governance with all proposals approved and a proactive step to enhance shareholder value through a share repurchase program. Management expresses confidence in the company's long-term value and strategic direction, including its unique Bitcoin treasury operations.
Positives
- The Board authorized a share repurchase program of up to $10 million, reflecting confidence in the long-term value of the company and enhancing financial flexibility.
- All proposals presented at the annual meeting, including director elections and the corporate conversion, were approved by stockholders, indicating strong corporate governance and shareholder alignment.
- Management expressed a clear focus on deploying capital with discipline and intention to drive durable value for all shareholders.
Risks
- Bitcoin market volatility.
- Cybersecurity and custody of digital assets.
- Potential changes in laws or accounting standards relating to cryptocurrency.
- Regulatory developments affecting Bitcoin or other digital assets.
- Risk that changes in the company's capital structure and governance could have adverse effects on the market value of its securities.
- The ability of the company to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers.
- The risk that the company may be unable to reduce expenses or access financing or liquidity.
- The impact of any related economic downturn.
- The risk of changes in governmental regulations or enforcement practices.
- Adverse impacts from geopolitical events, health crises, supply chain disruptions, changes to laws or accounting standards, cybersecurity threats or data breaches, intellectual property disputes, competitive pressures, or changes in consumer behavior.
Future Outlook
The company intends to continue its strategic priorities, balancing investments with actions to drive durable shareholder value, including the newly authorized share repurchase program. KindlyMD, through its subsidiary Nakamoto Holdings, Inc., plans to grow its Bitcoin holdings through disciplined accumulation and leverage its treasury to acquire and develop an ecosystem of Bitcoin companies across finance, media, and advisory, aiming to provide commercial and financial infrastructure for future capital markets.
Management Comments
- "This share repurchase program reflects our confidence in the long-term value of the Company and adds an important degree of flexibility to our capital allocation framework."
- "As shareholders ourselves, we remain focused on deploying capital with discipline and intention, balancing continued investment in our strategic priorities with actions we believe will drive durable value for all shareholders."
Industry Context
KindlyMD operates in two distinct but strategically linked sectors: integrated healthcare services and Bitcoin treasury management through its Nakamoto Holdings subsidiary. The share repurchase program signals financial stability and a commitment to shareholder returns, a common practice in mature companies. Its dual strategy of healthcare innovation and Bitcoin integration positions it uniquely, aiming to capitalize on both the evolving value-based care market and the emerging digital asset economy. This approach suggests a diversification strategy, potentially hedging against sector-specific risks while aiming for growth in high-potential areas.
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Class I Director | NA | Perianne Boring | 2025-12-17 | Elected by stockholders for a three-year term. |
| Class I Director | NA | Greg Xethalis | 2025-12-17 | Elected by stockholders for a three-year term. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Corporate Structure Conversion | Stockholders approved the conversion of Kindly MD from a Utah corporation to a Delaware corporation. | 2025-12-17 | This change typically offers benefits such as a well-established corporate law framework, greater flexibility for corporate actions, and often a more favorable environment for public companies and investors. |
| Auditor Ratification | Stockholders ratified the appointment of Sadler, Gibb & Associates, LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2025. | 2025-12-17 | Ensures continuity and independent oversight of financial reporting for the upcoming fiscal year. |
Stakeholder Impact
- Shareholders: Potential positive impact from the share repurchase program, which can reduce share count and potentially increase earnings per share, signaling management's confidence. Approval of all proposals indicates stable corporate governance.
- Management/Board: Continued mandate for current directors and strategic direction, including the Bitcoin treasury strategy.
- Employees/Customers: No direct impact mentioned, but a stable and confident company environment can indirectly benefit employees and customers.
- Creditors/Suppliers: No direct impact mentioned.
Next Steps
- KindlyMD will proceed with the repurchase of up to $10 million of its common stock under the 2025 Repurchase Program, with timing and amount determined by management based on market conditions and other factors.
- The newly elected Class I directors, Perianne Boring and Greg Xethalis, will serve for a term of three years, expiring at the 2028 annual meeting.
- The company will complete its conversion from a Utah corporation to a Delaware corporation.
- Sadler, Gibb & Associates, LLC will serve as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- The company will continue to pursue its strategy of integrating healthcare services with Bitcoin treasury management through Nakamoto Holdings, Inc.
Key Dates
| Date | Description |
|---|---|
| 2025-08-01 | KindlyMD completed its merger with Nakamoto Holdings Inc. |
| 2025-10-23 | Record date for the Annual Meeting of stockholders. |
| 2025-11-03 | Date Definitive Proxy Statement on Schedule 14A was filed with the SEC. |
| 2025-12-17 | Annual Meeting of stockholders held virtually. |
| 2025-12-18 | Board of Directors approved the 2025 Repurchase Program and the company issued a press release announcing it. |
| 2028-12-31 | Expected expiration of term for elected Class I directors (approximate, based on '2028 annual meeting'). |
Recommendation
buyThe approval of a $10 million share repurchase program signals strong management confidence in the company's intrinsic value and future prospects, which is typically a bullish indicator. All corporate governance proposals passed smoothly, indicating stability. The company's unique dual strategy in healthcare and Bitcoin treasury management, while carrying risks, also presents significant growth potential. The repurchase program, combined with management's stated focus on disciplined capital allocation, suggests a commitment to enhancing shareholder value.
Keywords
Share Repurchase Program, Stockholder Meeting, Corporate Governance, Bitcoin Strategy, Healthcare Services, NAKA, KindlyMD, Nakamoto Holdings, SEC Filing, 8-K
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.